Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.15420/icr.2016.11.1.47 http://scihub22266oqcxt.onion/10.15420/icr.2016.11.1.47 C5808707!5808707!29588705     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Interv+Cardiol 2016 ; 11 (1): 47-50 Nephropedia Template TP {{tp|p=29588705|t=2016. The use of the Cre8 Stent in Patients With Diabetes Mellitus |pdf=|usr=}}{{29588705}} gab.com Text The use of the Cre8 Stent in Patients With Diabetes Mellitus JO: Interv Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=29588705 #FOAvip Despite improved clinical outcomes following the availability of second-generation drug eluting stents (DES), percutaneous coronary intervention (PCI) is associated with worse clinical and angiographic outcomes among patients with diabetes mellitus (DM) than among non-diabetics. The Cre8? Amphilimus-eluting DES is polymer-free, resulting in a reduced inflammatory response and lower risk of stent thrombosis. It showed equivalent efficacy and safety in diabetic and non-diabetic populations, a unique finding among DES studies. These findings were confirmed in a real-world study called INVESTIG8. Another real-world study, pARTicip8, is ongoing. The RESERVOIR clinical trial recruited patients with diabetes mellitus and showed noninferiority of the Cre8 DES compared to an everolimus-eluting DES but showed a statistical superiority of Cre8 in diabetic patients with higher metabolic dysfunctions. The Cre8 DES is therefore a valuable option for this important patient population. Twit Text FOAVip The use of the Cre8 Stent in Patients With Diabetes Mellitus ????Interv Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=29588705 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29588705 #FOAvip English Wikipedia <ref>{{Cite pmid|29588705}}</ref> The use of the Cre8 Stent in Patients With Diabetes Mellitus #MMPMID29588705 Carrié D Interv Cardiol 2016[May]; 11 (1): 47-50 PMID29588705show ga Despite improved clinical outcomes following the availability of second-generation drug eluting stents (DES), percutaneous coronary intervention (PCI) is associated with worse clinical and angiographic outcomes among patients with diabetes mellitus (DM) than among non-diabetics. The Cre8? Amphilimus-eluting DES is polymer-free, resulting in a reduced inflammatory response and lower risk of stent thrombosis. It showed equivalent efficacy and safety in diabetic and non-diabetic populations, a unique finding among DES studies. These findings were confirmed in a real-world study called INVESTIG8. Another real-world study, pARTicip8, is ongoing. The RESERVOIR clinical trial recruited patients with diabetes mellitus and showed noninferiority of the Cre8 DES compared to an everolimus-eluting DES but showed a statistical superiority of Cre8 in diabetic patients with higher metabolic dysfunctions. The Cre8 DES is therefore a valuable option for this important patient population. äThe use of the Cre8 Stent in Patients With Diabetes Mellitus (epmc).pdf DeepDyve Pubget Overpricing